Market Overview

The Global Pneumococcal Vaccines Market is expected to grow at a CAGR of 8.30% during the forecasting period (2021-2028).

Pneumococcal Vaccines help prevent pneumococcal disease, which is a type of infection caused by Streptococcus pneumoniae bacteria.

Pneumococcal disease is contagious and can cause severe infections in the lungs, the lining of the brain, invasive pneumococcal disease, concomitant administration.

The spinal cord, and blood. It is more common in children, but it’s most likely to cause severe complications in adults.

Search for new vaccines is warranted as Streptococcus pneumoniae has developed resistance to several available drugs.

The genome of Streptococcus pneumoniae has been identified to contain new drug sites, hence aiding in developing newer drugs to treat Pneumococcal diseases.

Download free sample:

Market Growth Analysis

This report segments the pneumococcal vaccines market by product type, by dosage, by end-user, and region.

Based on product type, the market is classified into two categories, namely pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine.

Pneumococcal conjugate vaccines are newer while the pneumococcal polysaccharide or concomitant administration. The unconjugated vaccine is the older ones.

Based on end-user, the market is segmented into Infants/Young Children (2-10 Age), Young Adults/Adults (10-64 Age), and Geriatric (Over 65 Age).

Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.

Globally North America is the largest market for pneumococcal vaccines with significant demand concentrated in the US owing to the high incidence of infections caused by the pneumococcal disease every year in the US, with over 50,000 cases of pneumococcal bacteremia.

Segmentation Analysis

By Product Type

Pneumococcal conjugate vaccine

Pneumococcal polysaccharide vaccine

By End-User

Infants/Young Children (2-10 Age)

Adults/ Young Adults (10-64 Age)


By Region

North America


South America

Asia Pacific

Middle East and Africa

View full report:

Competitive Landscape

Some major key players in the global Pneumococcal Vaccines Market Company Profiles are Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline Plc., Sanofi Pasteur, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd. 

Trending Topics:

Cell Signaling Market

Oncolytic Virus Therapy Market

Preventive Vaccine Market

Precision Medicine Market

Monoclonal Antibody Therapeutics Market

Tags: GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Astellas Pharma Inc, Sanofi Pasteur, Pfizer Inc., Pneumococcal Vaccines Market, pneumococcal,  Vaccines, Pneumococcal Vaccines, Merck & Co.

See Campaign:
Contact Information:
Sai Kiran Sales Manager at DataM Intelligence Email: [email protected] Tel: +1 877 441 4866 Website:

PR-Wirein, Reportedtimes, Menafn, Extended Distribution, iCN Internal Distribution, Research Newswire, English